Global /United States /Healthcare /Diagnostics & Research /IDXX
chevron_leftBack

IDEXX Laboratories, Inc.

IDXX
NASDAQ: IDXX Delayed
426.63USD 1.2%
As of 24 April 2025, IDEXX Laboratories, Inc. has a market cap of $34.57B USD, ranking #563 globally and #263 in the United States. It ranks #51 in the Healthcare sector, and #4 in the Diagnostics & Research industry.
Global Rank
563
Country Rank
263
Sector Rank
51
Industry Rank
4
Key Stats
Market Cap
$34.57BUSD
Enterprise Value
$35.27BUSD
Revenue (TTM)
$3.9BUSD
EBITDA (TTM)
$1.32BUSD
Net Income (TTM)
$887.87MUSD
EBITDA Margin
34%
Profit Margin
23%
PE Ratio
40.0
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Jonathan Mazelsky open_in_new
Employees
11,000
Founded
1983
IPO
21 Jun 1991
Website
idexx.com open_in_new
warningChart data may be delayed
1d 1w 1m 3m 6m 1y
1.2% 6% 1.3% -0.9% -7.6% -11%
Upcoming Earnings
Earnings Date
Thu, May 1
Earnings Time
sunny Before Open
EPS Estimate
$2.84 1.1% yoy
Revenue Estimate
$996.18M 3.3% yoy

Markets

Exchange Ticker Price
NASDAQ
MIC: XNAS
PRIMARY
IDXX
IDEXX Laboratories Inc
ISIN: US45168D1046
Shares Out.:
81.039M1 Shares Float: 80.203M2
TV:
SA:
YF:
GF:
NQ:
BA:
MS:
426.63 USD
London Stock Exchange
MIC: XLON
0J8P
IDEXX Laboratories Inc
ISIN: US45168D1046
TV:
SA:
YF:
GF:
BA:
MS:
410.47 USD
Mexican Bolsa
MIC: XMEX
IDXX
IDEXX Laboratories Inc
ISIN: US45168D1046
TV:
SA:
YF:
GF:
BA:
MS:
8.4K MXN
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.

About IDEXX Laboratories, Inc.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Similar Companies

Industry: Diagnostics & Research (United States)
Name
Market Cap diff.
Thermo Fisher Scientific Inc.
TMO
$162.94B
371%
Danaher Corp.
DHR
$140.49B
306%
Agilent Technologies, Inc.
A
$29.94B
-13%
IQVIA Holdings Inc.
IQV
$25.93B
-25%
Mettler-Toledo International Inc.
MTD
$21.8B
-37%
Industry: Diagnostics & Research (Global)
Name
Market Cap diff.
Lonza Group AG
LONN
$48.07B
39.7B CHF
39%
WuXi AppTec Co., Ltd.
603259
$22.16B
161.5B CNY
-36%
bioMérieux S.A.
BIM
$15.23B
13.39B EUR
-56%
ICON Public Limited Co.
ICLR
$11.56B
-67%
Eurofins Scientific SE
ERF
$11.46B
10.07B EUR
-67%